RxDoctor Payments Data

Gregor Blix

Urology · Kalamazoo, MINPI 1285672493

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $12,848 of the $15,297 with a category attached, or 84.0%. Medtronic accounts for 84.0% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $14,040 and has fallen 98.7% since, to $182 in 2023.

$15,297in general payments, 2019–2025

Across 96 payments — averaging $159.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$13K
  • Boston Scientific$927
  • Astellas Pharma US Inc$448
  • AbbVie$304
  • Myovant Sciences Inc.$103
  • Johnson & Johnson$89
  • plus $579 from 18 others

What the payments were for

  • Royalty or licence$12,84884%
  • Travel & lodging$6544%
  • Food & beverage$1,61611%
  • Education$1791%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,297 in reported general payments places this provider in the 85th percentile of 400 urology providers in Michigan.

See all urology providers in Michigan →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl78$1,392
Finasteride23$275

Paid to pharmacies, not to this prescriber.

Other urology in Kalamazoo

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →